BVS bioventus.com: Forward P/S Multiple

Graphic logo of Bioventus Corp (BVS)

Bioventus Inc. is implementing automated assembly lines to minimize defects in implant production. Technological superiority in R&D and the creation of smart tissue regeneration stimulators supports the company's projected P/S on GURU.Markets, where 1.20 forms the current metric value. The large-scale deployment of robotic sterile packaging and software for precision dosing of biomaterials completes the modernization of production cycles.

bioventus.com - BVS Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Bioventus Global (BVS)

- current price and projected stock value:
Stock Price Bioventus|BVS - Average Forecast Price
- company stock capitalization data:
Market Capitalization Bioventus Global|BVS - Business Value
- issuer book value statistics:
Book Value per Share Bioventus|BVS - Book Valuation of Business|Market Capitalization to Book Value Ratio bioventus.com|BVS - Cumulative Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital Bioventus Inc.|BVS - Long-Term Debt to Capital|Short-Term Debt to Equity Bioventus Inc.|BVS - Company Debts|Debt to Book Value Bioventus Global|BVS - Company Long-Term Loans and Borrowings|Company Short-Term Debts Bioventus|Quick Liquidity bioventus.com
- financial results and valuation multiples details:
BVS - Annual Net Income|Future Profit Bioventus Inc.|BVS - P/E Multiple|Forward P/E Multiple Bioventus Corp|BVS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bioventus Global|BVS - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Bioventus|BVS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth bioventus.com|BVS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Bioventus Inc.
- sales volume and revenue indicators:
BVS - Company Sales Volume|Company Future Sales Volume Bioventus|BVS - Market Cap to Sales Volume|Forward P/S Multiple Bioventus Global
Summary company analytics:Bioventus (BVS)
Product sample of Bioventus Inc.

The forward P/S ratio assesses the market value of Bioventus Inc. (BVS) relative to projected sales volumes, reflecting investor expectations for revenue growth rates. This metric is highly sensitive to changes in discount rates and the macroeconomic backdrop. By analyzing the expected price-to-sales ratio, one can track the business valuation dynamics between quarterly reports. For a company in the midst of debt restructuring, this indicator serves as a marker for the effectiveness of its transition toward organic growth.

Key competitors

Forward P/S Multiple BSX (Boston Scientific Corporation)|Edwards (EW) - Market Cap to Future Revenue Ratio|ResMed Corp - Forward P/S Multiple|PODD (Insulet Inc.) - Market Cap to Projected Revenue|ZBH: Forward P/S Multiple|COO - Market Cap to Expected Sales Ratio|ALGN (Align Technology) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Globus Medical Inc (GMED)|Forward P/S Multiple TMDX|Forward P/S Multiple Alphatec Corp (ATEC)|Price-to-Projected Revenue Ratio Artivion, Inc. AORT|enovis.com - Price-to-Projected Revenue Ratio|IART: Forward Price-to-Revenue Multiple|Forward Price to Sales ESTA (Establishment Labs Corp)|BBNX: Forward P/S Multiple|Market Cap to Future Revenue Ratio IRADIMED Inc. (IRMD)|Price-to-Projected Revenue Ratio Embecta Corp.|TNDM - Projected Price to Revenue|Forward Price-to-Revenue Multiple AXGN (Axogen)|Forward P/S Multiple SI-BONE Inc (SIBN)|Forward P/S Multiple OFIX (Orthofix International)|Market Cap to Expected Sales Ratio OrthoPediatrics Corp (KIDS)|TMCI - Price-to-Projected Revenue Ratio|Future Price to Revenue SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple RxSight Inc|CLPT (ClearPoint Neuro Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stereotaxis Corporation STXS|Price-to-Projected Revenue Ratio Neuronetics, Inc. (STIM)|sightsciences.com - Market Cap to Projected Revenue|Orchestra BioMed, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ANIK (Anika Therapeutics Inc.)|InspireMD Corp - Forward P/S Multiple|ZJYL: Price-to-Projected Revenue Ratio|VANI: Forward P/S Multiple|XTNT - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio NeuroOne Medical Technologies Corporation|Market Cap to Future Revenue Ratio Modular Med MODD|Forward Price-to-Revenue Multiple MYO (Myomo, Inc)|Price-to-Projected Revenue Ratio COCH (Envoy Medical Inc)|Forward P/S Multiple VVOS (Vivos Therapeutics)|envveno.com (NVNO) - Market Cap to Future Revenue Ratio|SINT - Price-to-Projected Revenue Ratio|TNON (Tenon Medical Inc.) - Market Cap to Projected Revenue|LFWD (ReWalk Robotics Ltd) - Forward Price-to-Revenue Multiple|AMIX: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple IVF|Forward P/S Multiple bonebiologics.com|Price-to-Projected Revenue Ratio Axonics (AXNX)|Market Cap to Expected Sales Ratio BIOLASE Inc.|Dynatronics - Forward Price-to-Revenue Multiple|Forward Price to Sales FNA|INVO Bio - Forward P/S Multiple